|
US8835358B2
(en)
|
2009-12-15 |
2014-09-16 |
Cellular Research, Inc. |
Digital counting of individual molecules by stochastic attachment of diverse labels
|
|
DK3246416T3
(da)
|
2011-04-15 |
2024-09-02 |
Univ Johns Hopkins |
Sikkert sekventeringssystem
|
|
CA2865575C
(en)
|
2012-02-27 |
2024-01-16 |
Cellular Research, Inc. |
Compositions and kits for molecular counting
|
|
ES2886507T5
(es)
|
2012-10-29 |
2024-11-15 |
Univ Johns Hopkins |
Prueba de Papanicolaou para cánceres de ovario y de endometrio
|
|
CN110964796B
(zh)
|
2013-08-28 |
2024-04-05 |
贝克顿迪金森公司 |
大规模平行单细胞分析
|
|
WO2016160844A2
(en)
|
2015-03-30 |
2016-10-06 |
Cellular Research, Inc. |
Methods and compositions for combinatorial barcoding
|
|
WO2017027653A1
(en)
|
2015-08-11 |
2017-02-16 |
The Johns Hopkins University |
Assaying ovarian cyst fluid
|
|
US10301677B2
(en)
|
2016-05-25 |
2019-05-28 |
Cellular Research, Inc. |
Normalization of nucleic acid libraries
|
|
US10202641B2
(en)
|
2016-05-31 |
2019-02-12 |
Cellular Research, Inc. |
Error correction in amplification of samples
|
|
KR102638006B1
(ko)
|
2016-09-26 |
2024-02-20 |
셀룰러 리서치, 인크. |
바코딩된 올리고뉴클레오티드 서열을 갖는 시약을 이용한 단백질 발현의 측정
|
|
US11414710B2
(en)
*
|
2016-12-28 |
2022-08-16 |
Quest Diagnostics Investments Llc |
Compositions and methods for detecting circulating tumor DNA
|
|
EP3610034B1
(en)
|
2017-04-12 |
2022-06-08 |
Karius, Inc. |
Sample preparation methods, systems and compositions
|
|
EP4345172A3
(en)
|
2017-06-05 |
2024-07-03 |
Becton, Dickinson and Company |
Sample indexing for single cells
|
|
CN111868260B
(zh)
|
2017-08-07 |
2025-02-21 |
约翰斯霍普金斯大学 |
用于评估和治疗癌症的方法和材料
|
|
WO2019195268A2
(en)
|
2018-04-02 |
2019-10-10 |
Grail, Inc. |
Methylation markers and targeted methylation probe panels
|
|
AU2019262048B2
(en)
|
2018-05-03 |
2025-09-04 |
Becton, Dickinson And Company |
High throughput multiomics sample analysis
|
|
CN120193081A
(zh)
|
2018-07-23 |
2025-06-24 |
夸登特健康公司 |
用于通过肿瘤分数和覆盖率调整肿瘤突变负荷的方法和系统
|
|
US12178549B2
(en)
|
2018-10-11 |
2024-12-31 |
Seno Medical Instruments, Inc. |
Optoacoustic image analysis method and system for automatically estimating lesion traits
|
|
AU2019351130B2
(en)
|
2018-09-27 |
2025-10-23 |
GRAIL, Inc |
Methylation markers and targeted methylation probe panel
|
|
CN118853827A
(zh)
|
2018-10-01 |
2024-10-29 |
贝克顿迪金森公司 |
确定5’转录物序列
|
|
CN112969789A
(zh)
|
2018-11-08 |
2021-06-15 |
贝克顿迪金森公司 |
使用随机引发的单细胞全转录组分析
|
|
EP3894552A1
(en)
|
2018-12-13 |
2021-10-20 |
Becton, Dickinson and Company |
Selective extension in single cell whole transcriptome analysis
|
|
CN113454218A
(zh)
*
|
2018-12-20 |
2021-09-28 |
夸登特健康公司 |
用于改进核酸分子的回收的方法、组合物和系统
|
|
EP3914728B1
(en)
|
2019-01-23 |
2023-04-05 |
Becton, Dickinson and Company |
Oligonucleotides associated with antibodies
|
|
AU2020212057A1
(en)
*
|
2019-01-25 |
2021-08-26 |
GRAIL, Inc |
Detecting cancer, cancer tissue of origin, and/or a cancer cell type
|
|
EP3918089B1
(en)
|
2019-01-31 |
2025-01-15 |
Guardant Health, Inc. |
Method for isolating and sequencing cell-free dna
|
|
CN113454234B
(zh)
|
2019-02-14 |
2025-03-18 |
贝克顿迪金森公司 |
杂合体靶向和全转录物组扩增
|
|
WO2020176659A1
(en)
|
2019-02-27 |
2020-09-03 |
Guardant Health, Inc. |
Methods and systems for determining the cellular origin of cell-free dna
|
|
WO2020229437A1
(en)
*
|
2019-05-14 |
2020-11-19 |
F. Hoffmann-La Roche Ag |
Devices and methods for sample analysis
|
|
EP3976822A1
(en)
|
2019-05-31 |
2022-04-06 |
Guardant Health, Inc. |
Methods and systems for improving patient monitoring after surgery
|
|
EP4004231B1
(en)
|
2019-07-22 |
2025-11-12 |
Becton, Dickinson and Company |
Single cell chromatin immunoprecipitation sequencing assay
|
|
JP7323703B2
(ja)
*
|
2019-08-19 |
2023-08-08 |
エフ． ホフマン－ラ ロシュ アーゲー |
配列決定用のｄｎａ及びｒｎａのシングルチューブ調製
|
|
WO2021067484A1
(en)
|
2019-09-30 |
2021-04-08 |
Guardant Health, Inc. |
Compositions and methods for analyzing cell-free dna in methylation partitioning assays
|
|
CN114729350A
(zh)
|
2019-11-08 |
2022-07-08 |
贝克顿迪金森公司 |
使用随机引发获得用于免疫组库测序的全长v(d)j信息
|
|
US11898199B2
(en)
|
2019-11-11 |
2024-02-13 |
Universal Diagnostics, S.A. |
Detection of colorectal cancer and/or advanced adenomas
|
|
ES3031713T3
(en)
*
|
2019-11-26 |
2025-07-10 |
Guardant Health Inc |
Methods, compositions and systems for improving the binding of methylated polynucleotides
|
|
WO2021127208A1
(en)
*
|
2019-12-20 |
2021-06-24 |
Accuragen Holdings Limited |
Methods and systems for disease detection
|
|
US11649497B2
(en)
|
2020-01-13 |
2023-05-16 |
Becton, Dickinson And Company |
Methods and compositions for quantitation of proteins and RNA
|
|
GB202000747D0
(en)
*
|
2020-01-17 |
2020-03-04 |
Institute Of Cancer Res |
Monitoring tumour evolution
|
|
EP4097228B1
(en)
|
2020-01-29 |
2024-08-14 |
Becton, Dickinson and Company |
Barcoded wells for spatial mapping of single cells through sequencing
|
|
CN115516108A
(zh)
|
2020-02-14 |
2022-12-23 |
约翰斯霍普金斯大学 |
评估核酸的方法和材料
|
|
WO2021173719A1
(en)
|
2020-02-25 |
2021-09-02 |
Becton, Dickinson And Company |
Bi-specific probes to enable the use of single-cell samples as single color compensation control
|
|
US20210285042A1
(en)
*
|
2020-02-28 |
2021-09-16 |
Grail, Inc. |
Systems and methods for calling variants using methylation sequencing data
|
|
WO2021202752A1
(en)
*
|
2020-03-31 |
2021-10-07 |
Guardant Health, Inc. |
Determining tumor fraction for a sample based on methyl binding domain calibration data
|
|
WO2021222828A1
(en)
|
2020-04-30 |
2021-11-04 |
Guardant Health, Inc. |
Methods for sequence determination using partitioned nucleic acids
|
|
EP4150117A4
(en)
*
|
2020-05-12 |
2024-05-29 |
The Board of Trustees of the Leland Stanford Junior University |
SYSTEM AND METHOD FOR GENE EXPRESSION AND SOURCE TISSUE INFRINGEMENT FROM CELL-FREE DNA
|
|
WO2021231455A1
(en)
*
|
2020-05-13 |
2021-11-18 |
Accuragen Holdings Limited |
Cell-free dna size detection
|
|
EP4150118A1
(en)
|
2020-05-14 |
2023-03-22 |
Becton Dickinson and Company |
Primers for immune repertoire profiling
|
|
US12241126B2
(en)
|
2020-05-14 |
2025-03-04 |
Guardant Health, Inc. |
Homologous recombination repair deficiency detection
|
|
US12467096B2
(en)
|
2020-05-15 |
2025-11-11 |
Universal Diagnostics, S.A. |
Methods and systems for identifying methylation biomarkers
|
|
AU2021276524A1
(en)
|
2020-05-22 |
2023-01-05 |
Aqtual, Inc. |
Methods for characterizing cell-free nucleic acid fragments
|
|
EP4407030B1
(en)
|
2020-06-02 |
2025-12-17 |
Becton, Dickinson and Company |
Oligonucleotides and beads for 5 prime gene expression assay
|
|
WO2022002424A1
(en)
|
2020-06-30 |
2022-01-06 |
Universal Diagnostics, S.L. |
Systems and methods for detection of multiple cancer types
|
|
WO2023282916A1
(en)
|
2021-07-09 |
2023-01-12 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
EP4179111B1
(en)
|
2020-07-10 |
2024-04-03 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
US11932901B2
(en)
|
2020-07-13 |
2024-03-19 |
Becton, Dickinson And Company |
Target enrichment using nucleic acid probes for scRNAseq
|
|
CN111826430A
(zh)
*
|
2020-07-24 |
2020-10-27 |
扬州大学 |
一种研究鸡PGCs中lncRNA和组蛋白甲基化酶共调控靶基因的方法
|
|
EP4585697A3
(en)
|
2020-07-30 |
2025-08-06 |
Guardant Health, Inc. |
Methods for isolating cell-free dna
|
|
CN116194589A
(zh)
|
2020-07-31 |
2023-05-30 |
贝克顿迪金森公司 |
用于转座酶可及染色质的单细胞测定
|
|
WO2022040147A1
(en)
*
|
2020-08-19 |
2022-02-24 |
Accuragen Holdings Limited |
Methods for selective cell-free nucleic acid analysis
|
|
JP2023540221A
(ja)
|
2020-08-25 |
2023-09-22 |
ガーダント ヘルス， インコーポレイテッド |
バリアントの起源を予測するための方法およびシステム
|
|
US20220162670A1
(en)
*
|
2020-09-30 |
2022-05-26 |
Guardant Health, Inc. |
Methods and systems to improve the signal to noise ratio of dna methylation partitioning assays
|
|
CA3195797A1
(en)
|
2020-10-23 |
2022-04-28 |
Andrew Kennedy |
Compositions and methods for analyzing dna using partitioning and base conversion
|
|
WO2022108946A1
(en)
|
2020-11-17 |
2022-05-27 |
Becton, Dickinson And Company |
Combined analysis of cell-free nucleic acids and single cells for oncology diagnostics
|
|
WO2022109343A1
(en)
|
2020-11-20 |
2022-05-27 |
Becton, Dickinson And Company |
Profiling of highly expressed and lowly expressed proteins
|
|
CA3199829A1
(en)
|
2020-11-30 |
2022-06-02 |
Guardant Health, Inc. |
Compositions and methods for enriching methylated polynucleotides
|
|
US12392771B2
(en)
|
2020-12-15 |
2025-08-19 |
Becton, Dickinson And Company |
Single cell secretome analysis
|
|
WO2022140629A1
(en)
*
|
2020-12-23 |
2022-06-30 |
Guardant Health, Inc. |
Methods and systems for analyzing methylated polynucleotides
|
|
EP4291679A1
(en)
|
2021-02-12 |
2023-12-20 |
Guardant Health, Inc. |
Methods and compositions for detecting nucleic acid variants
|
|
WO2022187867A1
(en)
*
|
2021-03-05 |
2022-09-09 |
The Trustees Of Columbia University In The City Of New York |
Methods to analyze methylomes in tumor and plasma cell-free dna
|
|
EP4302301A1
(en)
|
2021-03-05 |
2024-01-10 |
Guardant Health, Inc. |
Methods and related aspects for analyzing molecular response
|
|
WO2022192189A1
(en)
*
|
2021-03-09 |
2022-09-15 |
Claret Bioscience, Llc |
Methods and compositions for analyzing nucleic acid
|
|
EP4305200A1
(en)
|
2021-03-09 |
2024-01-17 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on off-target polynucleotide sequencing data
|
|
WO2022204730A1
(en)
|
2021-03-25 |
2022-09-29 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
EP4314340A4
(en)
*
|
2021-03-30 |
2024-11-27 |
Resolution Bioscience, Inc. |
COMPOSITIONS AND METHODS FOR SIMULTANEOUS GENETIC ANALYSIS OF MULTIPLE LIBRARIES
|
|
EP4326906A4
(en)
*
|
2021-04-23 |
2025-03-12 |
The Translational Genomics Research Institute |
Analysis of fragment ends in dna
|
|
WO2022251655A1
(en)
|
2021-05-28 |
2022-12-01 |
Guardant Health, Inc. |
Compositions and methods for assaying circulating molecules
|
|
EP4359562A1
(en)
|
2021-06-21 |
2024-05-01 |
Guardant Health, Inc. |
Methods and compositions for copy-number informed tissue-of-origin analysis
|
|
US20250283170A1
(en)
*
|
2021-07-12 |
2025-09-11 |
The Trustees Of The University Of Pennsylvania |
Modified adapters for enzymatic dna deamination and methods of use thereof for epigenetic sequencing of free and immobilized dna
|
|
WO2023056065A1
(en)
|
2021-09-30 |
2023-04-06 |
Guardant Health, Inc. |
Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
|
|
EP4426858A2
(en)
|
2021-11-02 |
2024-09-11 |
Guardant Health, Inc. |
Quality control method
|
|
EP4430396A1
(en)
|
2021-11-12 |
2024-09-18 |
Guardant Health, Inc. |
Method of analysis of methylated dna-binding proteins
|
|
WO2023122623A1
(en)
|
2021-12-21 |
2023-06-29 |
Guardant Health, Inc. |
Methods and systems for combinatorial chromatin-ip sequencing
|
|
WO2023122740A1
(en)
|
2021-12-23 |
2023-06-29 |
Guardant Health, Inc. |
Compositions and methods for detection of metastasis
|
|
WO2023147568A2
(en)
*
|
2022-01-28 |
2023-08-03 |
Flagship Pioneering Innovations Vi, Llc |
Compositions and methods for making and using an immortalized library
|
|
JP2025513786A
(ja)
|
2022-04-07 |
2025-04-30 |
ガーダント ヘルス， インコーポレイテッド |
無細胞核酸分子のメチル化状態に基づいた腫瘍の存在の検出
|
|
EP4547857A1
(en)
|
2022-06-30 |
2025-05-07 |
Guardant Health, Inc. |
Enrichment of aberrantly methylated dna
|
|
JP2025523964A
(ja)
|
2022-07-21 |
2025-07-25 |
ガーダント ヘルス， インコーポレイテッド |
試料調製により誘発されるメチル化アーチファクトの検出および低減のための方法
|
|
WO2024040006A2
(en)
*
|
2022-08-15 |
2024-02-22 |
Bioscreening & Diagnostics Llc |
Ai and ml-based system to predict cancer from epigenetic data
|
|
WO2024059840A1
(en)
|
2022-09-16 |
2024-03-21 |
Guardant Health, Inc. |
Compositions and methods for analyzing soluble proteins
|
|
WO2024073508A2
(en)
|
2022-09-27 |
2024-04-04 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
KR20250110272A
(ko)
|
2022-11-15 |
2025-07-18 |
가던트 헬쓰, 인크. |
순환 종양 dna (ctdna)로부터 기준선 ctdna 수준 및 시간 경과에 따른 ctdna 수준의 종단적 변화 둘 다로부터의 신호를 이용하여 비소세포 폐암 (nsclc) 환자 약물 반응 또는 사망 또는 암 진행까지의 시간을 예측하는 방법
|
|
CN120569782A
(zh)
|
2022-12-21 |
2025-08-29 |
夸登特健康公司 |
基于无细胞核酸分子的甲基化状态检测同源重组缺陷
|
|
WO2024137880A2
(en)
|
2022-12-22 |
2024-06-27 |
Guardant Health, Inc. |
Methods involving methylation preserving amplification with error correction
|
|
EP4638782A2
(en)
|
2022-12-22 |
2025-10-29 |
Guardant Health, Inc. |
Integrated targeted and whole genome somatic and dna methylation sequencing workflows
|
|
EP4649489A1
(en)
|
2023-01-11 |
2025-11-19 |
Guardant Health, Inc. |
Joint modeling of longitudinal and time-to-event data to predict patient survival
|
|
EP4655416A1
(en)
|
2023-01-25 |
2025-12-03 |
Guardant Health, Inc. |
Nucleic acid methylation profiling method
|
|
WO2024186768A1
(en)
*
|
2023-03-07 |
2024-09-12 |
Guardant Health, Inc. |
Hybrid ssdna- and dsdna-ngs library preparation methods
|
|
US20250101522A1
(en)
|
2023-04-12 |
2025-03-27 |
Guardant Health, Inc. |
Brca1 promoter methylation in sporadic breast cancer patients detected by liquid biopsy
|
|
WO2024229143A1
(en)
|
2023-05-01 |
2024-11-07 |
Guardant Health, Inc. |
Quality control method for enzymatic conversion procedures
|
|
WO2024229433A1
(en)
|
2023-05-03 |
2024-11-07 |
Guardant Health, Inc. |
Methods for analysis of dna methylation
|
|
WO2024233502A1
(en)
|
2023-05-05 |
2024-11-14 |
Guardant Health, Inc. |
Cell-free dna blood-based test for cancer screening
|
|
US20240420800A1
(en)
|
2023-06-15 |
2024-12-19 |
Guardant Health, Inc. |
METHOD FOR HRD DETECTION IN TARGETED cfDNA SAMPLES USING DE NOVO MUTATIONAL SIGNATURES
|
|
WO2024264065A1
(en)
|
2023-06-23 |
2024-12-26 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell nucleic acids
|
|
WO2025007034A1
(en)
|
2023-06-29 |
2025-01-02 |
Guardant Health, Inc. |
Methods for determining surveillance and therapy for diseases
|
|
WO2025007038A1
(en)
|
2023-06-30 |
2025-01-02 |
Guardant Health, Inc. |
Methods for early detection of cancer
|
|
WO2025019297A1
(en)
|
2023-07-14 |
2025-01-23 |
Guardant Health, Inc. |
Classification of colorectal tumors using dna methylation from liquid biopsy
|
|
WO2025019370A1
(en)
*
|
2023-07-14 |
2025-01-23 |
Natera, Inc. |
Methods for assaying circulating tumor dna
|
|
WO2025019254A1
(en)
|
2023-07-14 |
2025-01-23 |
Guardant Health, Inc. |
Classification of breast tumors using dna methylation from liquid biopsy
|
|
WO2025024497A1
(en)
|
2023-07-24 |
2025-01-30 |
Guardant Health, Inc. |
Significance modeling of clonal-level target variants using methylation detection
|
|
WO2025029645A1
(en)
|
2023-07-28 |
2025-02-06 |
Guardant Health, Inc. |
Methods and systems for identifying an origin of a variant
|
|
WO2025029475A1
(en)
|
2023-07-28 |
2025-02-06 |
Guardant Health, Inc. |
Methods to enrich nucleotide variants by negative selection
|
|
US20250218587A1
(en)
|
2023-07-31 |
2025-07-03 |
Guardant Health, Inc. |
Methods and systems for identifying tumor origin
|
|
WO2025038399A1
(en)
|
2023-08-11 |
2025-02-20 |
Guardant Health, Inc. |
Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
|
|
US20250084469A1
(en)
|
2023-09-12 |
2025-03-13 |
Guardant Health, Inc. |
Methods for analyzing nucleic acids using sequence read family size distribution
|
|
WO2025064706A1
(en)
|
2023-09-19 |
2025-03-27 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
WO2025064489A1
(en)
|
2023-09-20 |
2025-03-27 |
Guardant Health, Inc. |
Systems and methods for real world evidence database data integration
|
|
WO2025072084A1
(en)
*
|
2023-09-25 |
2025-04-03 |
Foundation Medicine, Inc. |
Updating records based on consensus annotations of genetic variants
|
|
WO2025072467A1
(en)
|
2023-09-29 |
2025-04-03 |
Guardant Health, Inc. |
Genotyping cyp2d6
|
|
WO2025076425A1
(en)
|
2023-10-06 |
2025-04-10 |
Guardant Health, Inc. |
Genomic and methylation biomarkers for prediction of copy number loss / gene deletion
|
|
WO2025085784A1
(en)
|
2023-10-18 |
2025-04-24 |
Guardant Health, Inc. |
Genomic and methylation biomarkers for determining patient risk of heart disease and novel genomic and epigenomic drug targets to decrease risk of heart disease and/or improve patient outcome after myocardial infarction or cardiac injury
|
|
WO2025090954A1
(en)
|
2023-10-26 |
2025-05-01 |
Guardant Health, Inc. |
Methods for detecting nucleic acid variants
|
|
WO2025090956A1
(en)
|
2023-10-26 |
2025-05-01 |
Guardant Health, Inc. |
Methods for detecting nucleic acid variants using capture probes
|
|
WO2025106796A1
(en)
|
2023-11-15 |
2025-05-22 |
Guardant Health, Inc. |
Non-small cell lung cancer (nsclc) histology classification using dna methylation data captured from liquid biopsies
|
|
WO2025106263A1
(en)
|
2023-11-15 |
2025-05-22 |
Guardant Health, Inc. |
Joint modeling of longitudinal and time-to-event data to predict patient survival
|
|
WO2025106837A1
(en)
|
2023-11-15 |
2025-05-22 |
Guardant Health, Inc. |
Tumor fraction and outcome association in a real-world non-small cell lung cancer (nsclc) cohort using a methylation-based circulating tumor dna (ctdna) assay
|
|
US20250243550A1
(en)
|
2023-11-15 |
2025-07-31 |
Guardant Health, Inc. |
Minimum residual disease (mrd) detection in early stage cancer using urine
|
|
WO2025137620A1
(en)
|
2023-12-21 |
2025-06-26 |
Guardant Health, Inc. |
Methods for high quality and high accuracy methylation sequencing
|
|
WO2025160433A1
(en)
|
2024-01-24 |
2025-07-31 |
Guardant Health, Inc. |
Methods for analyzing sequencing reads
|
|
WO2025207817A1
(en)
|
2024-03-26 |
2025-10-02 |
Guardant Health, Inc. |
Method of determining the likelihood of a disease by combining biomarkers and imaging
|
|
WO2025207788A1
(en)
|
2024-03-27 |
2025-10-02 |
Guardant Health, Inc. |
Inferring cnvs from the distribution of molecules in hyper partition
|
|
WO2025207921A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for methylation enrichment using cpg-specific deamination
|
|
WO2025208044A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for cancer detection using molecular patterns
|
|
WO2025212664A1
(en)
|
2024-04-01 |
2025-10-09 |
Guardant Health, Inc. |
Small variant calling with error-rate based model
|
|
WO2025235602A1
(en)
|
2024-05-07 |
2025-11-13 |
Guardant Health, Inc. |
Predictive, prognostic signatures for immuno-oncology using liquid biopsy
|
|
WO2025235889A1
(en)
|
2024-05-10 |
2025-11-13 |
Guardant Health, Inc. |
Methods involving multiplexed pooled pcr
|
|
WO2025245433A1
(en)
|
2024-05-23 |
2025-11-27 |
Guardant Health, Inc. |
Generalized probabilistic generative modeling method for analysis of tumor methylated molecules in target capture regions
|
|
WO2025250544A1
(en)
|
2024-05-31 |
2025-12-04 |
Guardant Health, Inc. |
Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
|
|
US12467087B1
(en)
|
2024-06-25 |
2025-11-11 |
Guardant Health, Inc. |
Sequencing methods with partitioning
|